NASDAQ:PRME

Prime Medicine, Inc.

Stock

USD

Last Close

3.50

25/09 14:38

Market Cap

666.17M

Beta: -

Volume Today

173.35K

Avg: 197.03K

PE Ratio

−3.44

PFCF: −3.82

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-2.53M -	-3.41M 34.84%	-165.37M 4,749.47%	-121.82M 26.33%	-198.13M 62.64%
depreciation and amortization		43K -	568K 1,220.93%	2.22M 291.55%	4.65M 109.22%
deferred income tax		1.87M -	-624K 133.42%	-964K 54.49%	-279K 71.06%
stock based compensation		391K -	1.75M 346.55%	6.46M 269.93%	13.91M 115.36%
change in working capital	492K -	164K 66.67%	31.18M 18,909.76%	-35.40M 213.55%	2.65M 107.48%
accounts receivables
inventory
accounts payables		250K -	1.19M 374%	2.46M 107.43%	9.14M 271.85%
other working capital	492K -	-86K 117.48%	29.99M 34,973.26%	-37.86M 226.23%	-9.14M 75.86%
other non cash items	703K -	-4.60M 754.20%	98.42M 2,240.01%	17.68M 82.04%	11.79M 33.30%
net cash provided by operating activities	-1.33M -	-5.54M 315.59%	-34.08M 514.75%	-131.83M 286.79%	-165.41M 25.48%
investments in property plant and equipment		-639K -	-4.15M 549.45%	-16.09M 287.83%	-8.72M 45.80%
acquisitions net
purchases of investments			-81.98M -	-123.34M 50.45%	-104.95M 14.91%
sales maturities of investments			13M -	93M 615.38%	132.56M 42.53%
other investing activites		-423K -	-496K 17.26%	-665K 34.07%	-170K 74.44%
net cash used for investing activites		-1.06M -	-73.63M 6,832.77%	-47.10M 36.03%	18.71M 139.73%
debt repayment
common stock issued	9.98M -	34.95M 250.21%	270.36M 673.49%	185.32M 31.46%	655K 99.65%
common stock repurchased
dividends paid
other financing activites	29.94K -	-20K 166.79%	-1.09M 5,330%	-3.82M 252.03%
net cash used provided by financing activities	9.98M -	34.93M 250.01%	269.28M 670.82%	181.49M 32.60%	655K 99.64%
effect of forex changes on cash
net change in cash	8.65M -	28.33M 227.60%	161.57M 470.35%	2.57M 98.41%	-146.05M 5,780.51%
cash at beginning of period		8.65M -	36.98M 327.60%	198.54M 436.97%	201.12M 1.29%
cash at end of period	8.65M -	36.98M 327.60%	198.54M 436.97%	201.12M 1.29%	55.07M 72.62%
operating cash flow	-1.33M -	-5.54M 315.59%	-34.08M 514.75%	-131.83M 286.79%	-165.41M 25.48%
capital expenditure		-639K -	-4.15M 549.45%	-16.09M 287.83%	-8.72M 45.80%
free cash flow	-1.33M -	-6.18M 363.49%	-38.23M 518.34%	-147.92M 286.91%	-174.14M 17.72%

All numbers in USD (except ratios and percentages)